David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CALL
Polaris
PII
$3.63B
| $3.18M | ﹤0.01% |
37,700
-86,800
| -70% | -$7.36M |
|
1802
PUT
Herbalife
HLF
$1.3B
| $3.18M | ﹤0.01% |
60,000
+51,900
| +641% | +$2.98M |
|
1803
Elastic
ESTC
$8.24B
| $3.16M | ﹤0.01% |
+39,601
| New | +$3.31M |
|
|
EA
1804
CALL
DELISTED
Electronic Arts
EA
| $3.15M | ﹤0.01% |
31,000
| – | – |
|
1805
CALL
O'Reilly Automotive
ORLY
$72.4B
| $3.15M | ﹤0.01% |
121,500
-103,500
| -46% | -$2.5M |
|
1806
PUT
Okta
OKTA
$23.4B
| $3.14M | ﹤0.01% |
38,000
+12,500
| +49% | +$989K |
|
|
HOLI
1807
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $3.14M | ﹤0.01% |
150,092
-157,023
| -51% | -$3.23M |
|
|
CLR
1808
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $3.14M | ﹤0.01% |
70,100
-1,700
| -2% | -$76K |
|
1809
PUT
McCormick & Company Non-Voting
MKC
$14.8B
| $3.13M | ﹤0.01% |
41,600
-104,800
| -72% | -$7.07M |
|
1810
Heartland Express
HTLD
$964M
| $3.13M | ﹤0.01% |
162,329
+100,836
| +164% | +$2M |
|
1811
Daktronics
DAKT
$942M
| $3.13M | ﹤0.01% |
419,797
+3,411
| +0.8% | +$26.4K |
|
1812
A.O. Smith
AOS
$8.49B
| $3.12M | ﹤0.01% |
58,484
+14,171
| +32% | +$704K |
|
|
CYOU
1813
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $3.11M | ﹤0.01% |
181,623
+123,801
| +214% | +$2.32M |
|
1814
PUT
Occidental Petroleum
OXY
$58.6B
| $3.1M | ﹤0.01% |
46,900
-14,100
| -23% | -$929K |
|
1815
BlackRock TCP Capital
TCPC
$347M
| $3.1M | ﹤0.01% |
218,543
+106,506
| +95% | +$1.52M |
|
1816
Edwards Lifesciences
EW
$52.3B
| $3.1M | ﹤0.01% |
48,576
-16,461
| -25% | -$939K |
|
1817
Dominion Energy
D
$58.8B
| $3.1M | ﹤0.01% |
40,364
-892,667
| -96% | -$65.2M |
|
|
STMP
1818
DELISTED
Stamps.com, Inc.
STMP
| $3.09M | ﹤0.01% |
37,937
+28,629
| +308% | +$4.03M |
|
1819
PUT
Alnylam Pharmaceuticals
ALNY
$32B
| $3.08M | ﹤0.01% |
32,900
-13,400
| -29% | -$1.12M |
|
|
NVO
1820
Novo Nordisk
NVO
$209B
| $3.06M | ﹤0.01% |
117,136
-203,804
| -64% | -$5.01M |
|
1821
CALL
Bread Financial
BFH
$4.13B
| $3.04M | ﹤0.01% |
21,802
-40,848
| -65% | -$5.56M |
|
1822
State Street Communication Services Select Sector SPDR ETF
XLC
$22.7B
| $3.04M | ﹤0.01% |
+65,000
| New | +$2.96M |
|
1823
Sun Life Financial
SLF
$44B
| $3.03M | ﹤0.01% |
78,800
-148,100
| -65% | -$5.44M |
|
1824
Genesco
GCO
$384M
| $3.03M | ﹤0.01% |
66,463
+34,088
| +105% | +$1.56M |
|
1825
Team
TISI
$105M
| $3.02M | ﹤0.01% |
17,263
+2,180
| +14% | +$345K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.